Illumina To Webcast Upcoming Investor Conference
Illumina will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, with a fireside chat scheduled for 11:00 am PT (2:00 pm ET).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, with a fireside chat scheduled for 11:00 am PT (2:00 pm ET). The event will be accessible via a live webcast found in the Investor Info section of the company's website. A recorded replay will be available for at least 30 days after the event. Illumina, a leader in DNA sequencing technology, aims to enhance human health by harnessing the potential of the genome across various fields including life sciences and oncology.
Details
News Market Reaction – ILMN
The recorded move for ILMN in the trading session of this news was +0.04%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:
- Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021
Fireside Chat at 11:00 am Pacific Time (2:00 pm Eastern Time)
The live webcast can be accessed under the Investor Info section of the "company" tab at www.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Brian Blanchett
+1.858.291.6421
ir@illumina.com
Media:
Dr. Karen Birmingham
+1.646.355.2111
kbirmingham@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301365472.html
SOURCE Illumina, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.